Dr. Elisa Scarselli (Nouscom CSO) invited speaker at EHTG European Hereditary Tumour Group 2023, Vilnius September 28 – October 1st

 In Presentations

PRESENTATION TITLE: Nous-209 genetic vaccine encoding shared cancer neoantigens has demonstrated safety and robust immunogenicity in patients with Microsatellite Instable Tumors and is under evaluation in Lynch syndrome carriers.

Please find the full report below:

Recent Posts
error: Content is protected !!!